Results 251 to 260 of about 125,674 (260)

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Leukemia, 2014
A. Mian, Anahita Rafiei, I. Haberbosch, Alexey A. Zeifman, I. Titov, V. S. Stroylov, Anna Metodieva, O. Stroganov, F. Novikov, Boris Brill, G. Chilov, Dieter Hoelzer, O. Ottmann, M. Ruthardt   +13 more
semanticscholar   +1 more source

BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP

Leukemia, 2014
A. Morotti, C. Panuzzo, S. Crivellaro, Barbara Pergolizzi, U. Familiari, A. Berger, A. Berger, G. Saglio, P. Pandolfi   +8 more
semanticscholar   +1 more source

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.

Blood, 2000
F. Mahon, M. Deininger, B. Schultheis, J. Chabrol, J. Reiffers, J. Goldman, J. Melo   +6 more
semanticscholar   +1 more source

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

Science, 1986
Y. Ben-Neriah, G. Daley, A. Mes-Masson, O. Witte, D. Baltimore   +4 more
semanticscholar   +1 more source

BCR/ABL Oncogene

2001
openaire   +1 more source

Bcr-Abl tyrosine kinase

Science-Business eXchange, 2008
openaire   +1 more source

BCR‐ABL Fusion Protein

2008
openaire   +1 more source

Signaling through Bcr/Abl

2002
MOROTTI, Alessandro, SAGLIO, Giuseppe
openaire   +1 more source

[Signal transduction BCR-ABL fusion protein: analysis of BCR-ABL functional domains].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1998
T, Tauchi, S, Okabe, K, Oyashiki, K, Sotoyama   +3 more
openaire   +1 more source

Nowotwory mieloproliferacyjne BCR-ABL(-)

Hematologia, 2011
openaire